**INTRODUCTION:** Breast cancer is the most common malignant tumor in women. Mastectomy with immediate breast reconstruction is performed in 25--40% of this group. The commonest form of breast reconstruction is with an implant and a biological mesh.^1^ The mesh sheet supports the lower pole of the implant and reduces its weight on the skin envelope, reduces the post-surgical complication rate (particularly capsular contraction) and improves the aesthetic result. Seroma is the only complication shown to be more common when ADMs are used as compared to total muscle coverage without ADM. In light of the many advantages of using ADMs, there have been an increasing number options of biological mesh materials and designs used in breast reconstruction.

Today, there is little comparative information between different ADMs and their incorporation process in human use or animal models.^2,3,4,5^ Moreover, the relationship between fenestration of ADM sheets, such as perforation with widely spaced slits or holes, or more densely spaced meshed expandable or non-expandable patterns, and the adherence and incorporation of ADMs to opposing soft tissues has not been well studied.

**METHODS:** Alloderm, FlexHD, HuMend, Strattice and SurgiMend were implanted in a subcutaneous pocket on a pig's back. Each ADM type had at least two samples. Half of the samples were meshed 1:2.5. Tissues were collected at 3 months.

**RESULTS:** At three months, all ADM sheets were incorporated. Meshed ADM showed fewer giant cells and less foreign body reaction, demonstrated fewer inflammatory cells, deeper fibroblasts penetration and more remodeling with mature native porcine collagen.

**CONCLUSION:** Meshing ADM allows cells to populate fenestrations, promoting vascularization and production of neo-collagen. This leads to faster incorporation and remodeling in all ADM types. Our study sets the histological basis for further clinical investigations which may demonstrate lower surgical costs and lower complication rate with meshed ADM, in particular, seroma formation.
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